2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine,
2-(difluoromethyl)-1-(4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl)-1H-benzimidazole,
ZSTK474,
ZSTK474,
475110-96-4,
ZSTK-474,
4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine,
ZSTK 474,
TCMDC-137004,
UNII-K0068GK39A,
2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine,
CHEMBL586702,
CHEBI:90545,
K0068GK39A,
2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine,
AK-40326,
2-(Difluoromethyl)-1-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)-1h-Benzimidazole,
C19H21F2N7O2,
2wxl,
PubChem22461,
SCHEMBL373282,
GTPL7965,
QCR-72,
CTK8B6247,
DTXSID30197179,
SYN1099,
ZSTK474/ZSTK-474/,
BCPP000001,
HMS2043A02,
HMS3265I19,
HMS3265I20,
HMS3265J19,
HMS3265J20,
HMS3654I15,
BCP01867,
EX-A2207,
ZINC1912926,
ABP000085,
ANW-53118,
BDBM50315213,
MFCD08705334,
RS0114,
AKOS005145982,
AN-1513,
CS-0083,
DB12904,
EX-3329,
SB17043,
NCGC00346484-01,
NCGC00346484-08,
AC-28418,
AJ-32231,
AS-16245,
BC660052,
HY-50847,
SC-27986,
AB0007910,
AX8160720,
TC-061813,
FT-0083481,
FT-0651454,
S1072,
ST24028648,
SW220182-1,
X7419,
EC-000.2321,
S-7753,
110Z964,
I06-2249,
J-513955,
BRD-K63068307-001-01-4,
4,4'-(6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-,
ZSTK-474, ZST K474, 475110-96-4,
1-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-1H-benzimidazole,
1-[bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-1,3-benzodiazole,
2-(difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole,
2-(Difluoromethyl)-1-(4,6-dimorpholino-1,3,5-triazin-2-yl)-1H-benzo[d]imidazole,
2-(difluoromethyl)-1-(4,6-dimorpholino-1,3,5-triazin-2-yl)-1H-benzo[d]imidazole;ZSTK474,
2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole,
2-(difluoromethyl)-1-[4,6-di(morpholin-4-yl)-1,3,5-triazin-2-yl]benzimidazole,
4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine,
4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholino-1,3,5-triazin-2-yl]morpholine,
4,4''-(6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine,
4,4-(6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine,
ZS4,
D0O1LD,
cc-503,
ZSTK474/ZSTK-474,
CID11647372,
ZSTK474, 98% - 10MG 10mg,
A8248,
A11014,
A15585,
C510150,
2-(difluoromethyl)-1-(4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl)-1H-benzimidazole,
2-(difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)benzoimidazole,
2-(difluoromethyl)-1-(4,6-dimorpholino-1,3,5-triazin-2-yl)-1H-benzo[d]imidazole;,